Enstamont F Tablet is a combination medication containing Montelukast 10 mg and Fexofenadine 120 mg, formulated to provide effective relief from allergic conditions. Montelukast, a leukotriene receptor antagonist, works by blocking substances called leukotrienes that cause inflammation, bronchoconstriction, and mucus production in the airways, thereby alleviating symptoms associated with asthma and allergic rhinitis. Fexofenadine, a second-generation antihistamine, selectively inhibits peripheral H1 receptors, reducing the effects of histamine and providing symptomatic relief from allergic manifestations such as sneezing, nasal congestion, runny nose, and itching. The dual action of Enstamont F Tablet makes it particularly useful in managing seasonal allergic rhinitis, chronic urticaria, and other allergic disorders where both leukotriene-mediated inflammation and histamine release contribute to symptomatology. This combination offers the advantage of improved patient compliance by addressing multiple pathways involved in allergic responses with a single oral dose. Enstamont F is generally well-tolerated; however, patients should use it under medical supervision, especially those with hepatic impairment or a history of hypersensitivity to any component. It is not recommended for use in children below the prescribed age without physician guidance. Regular monitoring and adherence to prescribed dosage ensure optimal therapeutic outcomes.